Search

everythinglearnresearchcommunity

for

Search:↓

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Cooler scalp temperatures during chemotherapy may prevent hair loss.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

PLD is an effective and safer alternative for treating breast cancer.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.